Has the company actually provided any update on time frames for getting the wheels in motion for the clinical trial under a US IND application, with a view to getting the PRV?
In the announcement on July 2018 the company stated "The commencement date, duration, size and cost of the trial will not be precisely known until the Company has further discussions with the FDA".
It's been almost 2 months so would hope for an update soon.
Disclosure: previous shareholder. Just re-looking at RAC with a view to entering again!
RAC Price at posting:
10.5¢ Sentiment: None Disclosure: Not Held
